American Healthcare REIT, Inc. (NYSE:AHR - Get Free Report) declared a quarterly dividend on Wednesday, December 18th,Wall Street Journal reports. Stockholders of record on Tuesday, December 31st will be paid a dividend of 0.25 per share on Friday, January 17th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 3.68%. The ex-dividend date is Tuesday, December 31st.
American Healthcare REIT Stock Down 0.6 %
NYSE:AHR traded down $0.17 during mid-day trading on Thursday, hitting $27.21. The stock had a trading volume of 1,992,940 shares, compared to its average volume of 1,532,070. The company has a current ratio of 0.37, a quick ratio of 0.37 and a debt-to-equity ratio of 0.59. American Healthcare REIT has a twelve month low of $12.63 and a twelve month high of $29.99. The company has a market capitalization of $4.16 billion and a PE ratio of -56.69. The stock has a 50-day simple moving average of $27.08 and a two-hundred day simple moving average of $21.74.
American Healthcare REIT (NYSE:AHR - Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by ($0.35). American Healthcare REIT had a negative return on equity of 1.87% and a negative net margin of 1.84%. The firm had revenue of $523.81 million for the quarter, compared to analysts' expectations of $474.26 million. The firm's quarterly revenue was up 12.8% on a year-over-year basis. On average, equities research analysts anticipate that American Healthcare REIT will post 1.42 EPS for the current year.
Analysts Set New Price Targets
AHR has been the subject of a number of research analyst reports. Royal Bank of Canada upped their price target on American Healthcare REIT from $28.00 to $30.00 and gave the company an "outperform" rating in a report on Monday, November 18th. Truist Financial increased their target price on shares of American Healthcare REIT from $27.00 to $29.00 and gave the company a "buy" rating in a research report on Friday, November 15th. Colliers Securities raised shares of American Healthcare REIT from a "hold" rating to a "moderate buy" rating in a research report on Sunday, October 13th. Morgan Stanley upped their price objective on shares of American Healthcare REIT from $17.00 to $22.00 and gave the company an "overweight" rating in a research note on Thursday, August 22nd. Finally, Bank of America lifted their target price on American Healthcare REIT from $27.00 to $31.00 and gave the stock a "buy" rating in a research report on Tuesday, September 24th. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $25.13.
Check Out Our Latest Research Report on AHR
American Healthcare REIT Company Profile
(
Get Free Report)
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
Featured Stories
Before you consider American Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.
While American Healthcare REIT currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.